Refresh, Renew, Rejuvenate

Refresh Your Look While Feeling Great

Look and feel your best with our Medi-Spa services. Pointe Medical Services incorporates into our practice medi-spa services to enhance patient care. We hope you will try one of our new services the next time you visit us.
Our Medi-Spa Services Include:
  • Botox
  • Juvederm
  • Latisse
  • And more!
Woman with smooth skin feeling face

Own Your Look

One day you looked in the mirror and asked yourself a question about those lines that furrowed your brow: Where did they come from?
Is it aging? Too much stress? How skin ages and wrinkles is a complex process. It isn’t just about cellular changes, collagen depletion, hormone loss, damage caused by free radicals, and so on – it’s a combination of many factors.
Wrinkles: How do they get there?
The lines that appear between your brows, called glabellar lines, actually result from muscle movement and the passage of time. You may have heard the expression “wearing your emotions on your sleeve,” but in reality you wear them on your face! If you’re angry or annoyed you knit your brows together. Underneath your skin, your facial muscles contract, causing a pleating of the overlying skin, and then, as anyone can see, you’re frowning.
After years of wrinkling, those lines start to stay longer and become more pronounced. For women, whose faces tend to be more animated than men’s, and whose skin is typically more delicate, these lines sometimes appear exaggerated and more permanent.
Fortunately, there is a way to temporarily reduce moderate to severe glabellar lines. Treatment with BOTOX® Cosmetic can visibly smooth and soften moderate to severe frown lines between your brows. An improvement can be seen within days and may last up to 4 months, although results may vary. In clinical trials, nearly 90% of men and women surveyed rated the improvement in the appearance of frown lines between their brows as moderate to better 1 month after treatment.
Talk to your Pointe Medical Services doctor about whether BOTOX® Cosmetic is right for you.

Lift It. Smooth It. Plump It.

What Is JUVÉDERM® Injectable Gel?
As we age, our skin changes. Over time, the natural volume of youthful skin begins to diminish as wrinkles and folds form. But, with JUVÉDERM® injectable gel, you don’t have to just sit back and let it happen!
JUVÉDERM® is a smooth consistency gel made of hyaluronic acid — a naturally occurring substance in your skin that helps to add volume and hydration. JUVÉDERM® injectable gel is eased under the skin to instantly restore your skin’s volume and smooth away facial wrinkles and folds, like your “smile lines” or “parentheses” (nasolabial folds—the creases that run from the bottom of your nose to the corners of your mouth).
JUVÉDERM® provides a smooth, natural look and feel, so everyone will notice – but no one will know! Studies show superior results of JUVÉDERM® compared to a collagen-based dermal filler.
Almost 90% of all study volunteers who were treated with both JUVÉDERM® injectable gel and another dermal filler preferred JUVÉDERM®!
JUVÉDERM® injectable gel is the first FDA-approved hyaluronic acid dermal filler that is proven to be safe and effective for persons of color.
Immediate Results
With JUVÉDERM® the injection process takes only about 15 minutes and results are immediate. Plus, there’s minimal recovery or downtime, so you can step into your doctor’s office for treatment and step right back into your life.
Consult with your Pointe Medical Services doctor today to see if JUVÉDERM® injectable gel is right for you.

Are Your Lashes Thinning Over Time?

Latisse grows lashes longer, fuller and darker. LATISSE® is a prescription treatment for hypotrichosis (inadequate or not enough lashes).
If you use/used prescription products for eye pressure problems, use LATISSE® under doctor care. LATISSE® may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur and may be reversible. Only apply at the base of upper lashes. DO NOT APPLY to lower lid. Hair may grow on skin that LATISSE® frequently touches. If you have eye problems/surgery, consult your doctor about use of LATISSE®. Common side effects are itchy and red eyes. If discontinued, lashes gradually return to previous appearance.
Over-the-counter products condition eyelashes. Only LATISSE® has been approved by the FDA as a prescription treatment to grow eyelashes in people with inadequate or not enough eyelashes.

The US Food and Drug Administration (FDA) is the federal governmental agency charged with protecting the health and welfare of the US public by regulating prescription products. FDA regulations are extremely stringent, and when a drug is FDA approved, that means its efficacy and safety have been scientifically studied in valid clinical trials. FDA approval also requires the sponsoring pharmaceutical company to record all adverse events reported after the drug is approved.

LATISSE® received its FDA approval in December 2008.
Initial data from a group of women diagnosed with eyelash hypotrichosis in the LATISSE® clinical studies suggest that eyelashes may change over time. These are the trends that were suggested:
  • Length decreased with increasing age (based on assessment of 607 women)
  • Fullness decreased with increasing age (based on assessment of 468 women)
  • Darkness decreased with increasing age (based on assessment of 568 women)
Hypotrichosis is another name for having inadequate or not enough eyelashes.
In a clinical study of 278 participants, 78% of LATISSE® users (107/137) experienced a significant increase in overall eyelash prominence (including elements of length, fullness, and darkness) at week 16, versus 18% for the vehicle (26/141).* Lashes were:
  • 25% longer (2% for vehicle*)
  • 106% fuller (12% for vehicle*)
  • 18% darker (3% for vehicle*)
*Vehicle is the same solution as LATISSE® without the active ingredient.
LATISSE® is believed to prolong the anagen (active growth) phase. The exact way it works is unknown.
Patients should be informed that LATISSE® should be applied every night using only the accompanying sterile applicators. They should start by ensuring their face is clean, all makeup is removed, and their contact lenses are removed (if applicable). Then carefully place one drop of LATISSE® solution on the disposable sterile applicator and brush cautiously along the skin of the upper eyelid margin at the base of the eyelashes. If any LATISSE® solution gets into the eye, it is not expected to cause harm. The eye should not be rinsed. Patients should be informed not to apply to the lower eyelash line. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material.
Patients should be instructed that the LATISSE® bottle must be maintained intact and to avoid allowing the tip of the bottle or applicator to contact surrounding structures, fingers, or any other unintended surface in order to avoid contamination of the bottle or applicator by common bacteria known to cause ocular infections. Patients should also be instructed to only use the applicator supplied with the product once and then discard it, since reuse could result in using a contaminated applicator. Serious infections may result from using contaminated solutions or applicators.
Patients should not use LATISSE® solution if they are allergic to one of its ingredients.
Patients should tell their physician they are using LATISSE® especially if they have a history of eye pressure problems. They should also tell anyone conducting an eye pressure screening that they are using LATISSE® solution.

LATISSE® solution is intended for use on the skin of the upper eyelid margin at the base of the eyelashes. DO NOT APPLY to the lower lid. If patients are using LUMIGAN® (bimatoprost ophthalmic solution) or other products in the same class used for elevated intraocular pressure (IOP), or if they have a history of abnormal IOP, they should only use LATISSE® under the close supervision of their physician.

LATISSE® use may cause darkening of the eyelid skin, which may be reversible. LATISSE® use may also cause increased brown pigmentation of the colored part of the eye, which is likely to be permanent.

It is possible for hair growth to occur in other areas of the skin that LATISSE® frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if the patient stops using LATISSE® solution.
The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. These events occurred in less than 4% of patients.
Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.
Skin hyperpigmentation (or skin darkening) is a less common side effect that typically occurs close to where the solution is applied. The eyelid skin may look a little darker due to an increase of melanin in the skin. This is expected to reverse after several weeks to months if the patient stops using the product.
Patients’ lashes are expected to return to their previous appearance over several weeks to months.
It’s recommended that patients remove their contact lenses because LATISSE® solution contains benzalkonium chloride (BAK), and this may be absorbed by soft contact lenses. Contacts may be reinserted 15 minutes following LATISSE® administration.
Yes, patients can use mascara in addition to LATISSE® solution.
It’s important for patients to remember that LATISSE® solution works gradually. While they may start seeing longer lashes after 4 weeks, they must use LATISSE® every day for 16 weeks for full results. They should not reduce or stop daily application of LATISSE® solution when they first notice results. After 16 weeks, they should talk to their doctor about ongoing use. Individual results may vary.
No, LATISSE® should only be used with its FDA-approved sterile applicators, designed to help patients apply the product properly.
It is not expected to cause harm. Patients don’t need to rinse their eye. Reinforce the proper application instructions.

What is Xeomin®?

Frown lines form when facial expressions are made as the muscle under the skin contracts. Over time, as your skin ages, these repeated expressions cause lasting frown lines. Neurotoxins, such as Xeomin®, are prescription medications that block the release of chemicals that cause these muscle contractions so frown lines are softened.
When you squint or frown, the muscles between your eyebrows contract, causing the skin to furrow and fold. Over time, as your skin ages and loses some of its elasticity, these repeated contractions can cause persistent frown lines. Botulinum toxin type A – the active ingredient in Xeomin®– acts on nerve endings in muscles to prevent muscle fibers from contracting. By reducing these contractions, Xeomin® can temporarily reduce the lines between your eyebrows.
If you are an adult with moderate to severe glabellar lines, Xeomin® may be right for you. Talk to your doctor to discuss the benefits and risks of treatment.
You may begin to see visible smoothing as early as 3-4 days after injection. The median first onset of effect was less than a week. The maximum effect occurred at 30 days.
Looking and feeling your best starts here.
Get in touch today for a consultation.